Medication info
Diaryl Tablet 3 mg (Glymepiride)

Diaryl Tablet 3 mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›3mg / 1 tablet
Manufacturer / importer
Darim Biotech Co., Ltd.
Appearance
White rectangular tablet
Packaging
For domestic use: 100 tablets/bottle, 30 tablets/bottle; for export: 100 tablets/bottle, 30 tablets/bottle, 30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 200501372 · Notified 2005.06.27 · Insurance code 664600440

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses exceeding 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions provided under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has initially been successfully managed during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stable, capillary blood glucose should be monitored daily, whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Darim Biotech Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be administered alone, and if blood glucose control is insufficient with oral hypoglycemic agents, it can be used in combination with insulin. Additionally, if the effect of sulfonylureas or metformin monotherapy is inadequate, it may be used in combination with metformin to help control blood sugar. This medication effectively enhances blood sugar management, providing positive assistance in diabetes treatment.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses exceeding 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions provided under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has initially been successfully managed during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stable, capillary blood glucose should be monitored daily, whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a state of coma. Additionally, patients with allergies to this medication or components contained within it, as well as sulfonylurea drugs, should not take this medication. There have not been experiences using this medication in patients with severely impaired liver or kidney function, thus it is recommended to transition to insulin treatment in such cases. It is safer for women who are pregnant, may become pregnant, or are breastfeeding not to take this medication. For patients with severe infections, those undergoing surgery, or those with severe trauma, it is advisable to use insulin therapy. In cases of gastrointestinal disturbances such as diarrhea or vomiting, caution is needed as food absorption may be poor, increasing the risk of hypoglycemia. This medication contains lactose, so it should not be administered to patients with lactose intolerance or specific genetic issues. In the first week of treatment, the risk of hypoglycemia is high; thus, careful monitoring is particularly important for elderly patients or those with poor nutritional status or who skip meals, as well as those with impaired kidney or liver function, or those taking other medications, as they are at increased risk of hypoglycemia. Symptoms of hypoglycemia may include headache, severe hunger, fatigue, confusion, and decreased consciousness; if these symptoms occur, sugar should be ingested immediately. This medication may cause various side effects, including liver dysfunction, blood abnormalities, and allergic reactions, so if any abnormal signs appear, consult a physician immediately. It is important to combine dietary management and exercise therapy with this medication for blood sugar control, and rapidly consume sugar if hypoglycemia occurs. When receiving treatment at another hospital, it is essential to inform them of this medication use, and in stressful situations, surgery, or infections that can destabilize blood sugar, transitioning temporarily to insulin treatment may be necessary. This medication is excreted through the kidneys, so dosage adjustments are needed for elderly patients, and in cases of overdose, severe hypoglycemia may occur requiring immediate emergency treatment. When storing, keep it out of reach of children and store it in its original container for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, reduced agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, sensations of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased hepatic enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. Also, it is advisable to store the medication at a cool room temperature between 1 to 30 degrees Celsius. Storing it this way can help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White rectangular tablet

Package unit

For domestic use: 100 tablets/bottle, 30 tablets/bottle; for export: 100 tablets/bottle, 30 tablets/bottle, 30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.